MEETINGS - Conference entitled Evidence-Based Medicine: Optimizing Decision-Making to Improve Patient Care (US) May 2000:
This article was originally published in Clinica
The American Association of Clinical Chemistry (AACC) will hold a two-day conference entitled Evidence-Based Medicine: Optimizing Decision-Making to Improve Patient Care in Arlington, Virginia on May 19-20. For more information contact AACC in the US. Tel: +1 202 857 0717. Fax: +1 202 887 5093. Email: firstname.lastname@example.org
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.